Close Menu

NEW YORK (GenomeWeb News) – CVS Caremark the country’s largest pharmacy services provider, has decided to expand pharmacogenomic testing to its pharmacy benefit management customers to predict their responses to treatments for cancer, cardiovascular diseases, and HIV.

Generation Health, a company launched last year to help insurers, employers, and PBMs implement genetic testing with their systems, will help CVS Caremark put its pharmacogenomics testing programs in place, the companies said today.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Kelvin Droegemeier, the director of the White House Office of Science and Technology Policy, is the new acting director of the US National Science Foundation.

An opinion piece at the Guardian discusses the state of SARS-CoV-2 testing in the UK.

Wired reports the University of California, Berkeley's Innovative Genomics Institute has transformed itself into a diagnostic lab to run SARS-CoV-2 tests.

In Nature this week: direct-capture Perturb-seq approach for combinatorial single-cell CRISPR screens, potential uses of genome-editing in breeding crops, and more.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.